Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects.

BACKGROUND Extracellular vesicles or microparticles exhibiting procoagulant and thrombogenic activity may contribute to the haemostatic potential of fresh frozen plasma. MATERIALS AND METHODS Fresh frozen plasma was prepared from platelet-rich plasma at 20 °C (Group-1 donors) or directly from whole blood at 4 °C (Group-2 donors). Each unit was aseptically divided into three parts, stored frozen for specific periods of time, and analysed by flow cytometry for procoagulant activity immediately after thaw or following post-thaw storage for 24 h at 4 °C. Donors' haematologic, biochemical and life-style profiles as well as circulating microparticles were analysed in parallel. RESULTS Circulating microparticles exhibited a considerable interdonor but not intergroup variation. Fresh frozen plasma units were enriched in microparticles compared to plasma in vivo. Duration of storage significantly affected platelet- and red cell-derived microparticles. Fresh frozen plasma prepared directly from whole blood contained more residual platelets and more platelet-derived microparticles compared to fresh frozen plasma prepared from platelet-rich plasma. Consequently, there was a statistically significant difference in total, platelet- and red cell-derived microparticles between the two preparation protocols over storage time in the freezer. Preservation of the thawed units for 24 h at 4 °C did not significantly alter microparticle accumulation. Microparticle accumulation and anti-oxidant capacity of fresh frozen plasma was positively or negatively correlated, respectively, with the level of circulating microparticles in individual donors. DISCUSSION The preparation protocol and the duration of storage in the freezer, independently and in combination, influenced the accumulation of microparticles in fresh frozen plasma units. In contrast, storage of thawed units for 24 h at 4 °C had no significant effect on the concentration of microparticles.

[1]  R. Riganò,et al.  Crosstalk between Red Blood Cells and the Immune System and Its Impact on Atherosclerosis , 2015, BioMed research international.

[2]  E. Brojer,et al.  Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post‐transfusion reactions with dyspnoea , 2015, Vox sanguinis.

[3]  N. Juffermans,et al.  Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside. , 2015, Blood reviews.

[4]  C. Hillery,et al.  Circulating membrane-derived microvesicles in redox biology. , 2014, Free radical biology & medicine.

[5]  C. Coorey,et al.  The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles , 2014, Transfusion.

[6]  L. Horstman,et al.  Red cell-derived microparticles (RMP) as haemostatic agent , 2013, Thrombosis and Haemostasis.

[7]  N. Lion,et al.  Red blood cell–derived microparticles isolated from blood units initiate and propagate thrombin generation , 2013, Transfusion.

[8]  Ángel García,et al.  Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. , 2012, Journal of proteomics.

[9]  R. Sparrow,et al.  Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations. , 2012, Journal of proteomics.

[10]  M. Simionescu,et al.  Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? , 2012, Journal of cellular and molecular medicine.

[11]  F. Borràs,et al.  Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. , 2012, Journal of proteomics.

[12]  I. Papassideri,et al.  Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions? , 2012, Blood transfusion = Trasfusione del sangue.

[13]  P. Siljander,et al.  Platelet-Derived Microvesicles: Multitalented Participants in Intercellular Communication , 2012, Seminars in Thrombosis & Hemostasis.

[14]  C. Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[15]  J. Lovegrove,et al.  Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  D. Modun,et al.  Simple and Rapid Method for the Determination of Uric Acid-Independent Antioxidant Capacity , 2011, Molecules.

[17]  C. Wade,et al.  Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. , 2011, Thrombosis research.

[18]  N. Mackman,et al.  Microparticles in Hemostasis and Thrombosis , 2011, Circulation research.

[19]  György Nagy,et al.  Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2022 .

[20]  B. Ferry,et al.  Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. , 2011, Thrombosis research.

[21]  M. Macey,et al.  Flow cytometric analysis of microparticle phenotype and their role in thrombin generation , 2011, Cytometry. Part B, Clinical cytometry.

[22]  C. Wade,et al.  Multiple levels of degradation diminish hemostatic potential of thawed plasma. , 2011, The Journal of trauma.

[23]  R Lacroix,et al.  Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2010, Journal of thrombosis and haemostasis : JTH.

[24]  Christian Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[25]  A. D’Alessandro,et al.  Troubleshooting in platelet storage temperature and new perspectives through proteomics. , 2010, Blood transfusion = Trasfusione del sangue.

[26]  D. Connor,et al.  The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib , 2010, Thrombosis and Haemostasis.

[27]  N. Key.  Analysis of tissue factor positive microparticles. , 2010, Thrombosis research.

[28]  Fariborz Mobarrez,et al.  A multicolor flow cytometric assay for measurement of platelet-derived microparticles. , 2010, Thrombosis research.

[29]  L. Margaritis,et al.  Red blood cell aging markers during storage in citrate‐phosphate‐dextrose–saline‐adenine‐glucose‐mannitol , 2010, Transfusion.

[30]  R. Nieuwland,et al.  Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease , 2008, Haematologica.

[31]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[32]  A. Falanga,et al.  Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia , 2008, Haematologica.

[33]  J. Hansen,et al.  Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state. , 2009, Thrombosis research.

[34]  G. Bosman,et al.  Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion , 2008, Transfusion medicine.

[35]  R. Cardigan,et al.  The characterization and impact of microparticles on haemostasis within fresh‐frozen plasma , 2008, Vox sanguinis.

[36]  B. Furie,et al.  Mechanisms of thrombus formation. , 2008, The New England journal of medicine.

[37]  E. Lasonder,et al.  The proteome of red cell membranes and vesicles during storage in blood bank conditions. , 2008, Transfusion.

[38]  R. Cardigan,et al.  The dynamics of clot formation in fresh‐frozen plasma , 2008, Vox sanguinis.

[39]  Mona D. Shah,et al.  Flow cytometric measurement of microparticles: Pitfalls and protocol modifications , 2008, Platelets.

[40]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.

[41]  P. Maurya,et al.  Markers of Oxidative Stress in Erythrocytes during Aging in Humans , 2007, Annals of the New York Academy of Sciences.

[42]  Mikhail A Panteleev,et al.  Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets , 2007, Thrombosis and Haemostasis.

[43]  J. Heemskerk,et al.  Shedding of procoagulant microparticles from unstimulated platelets by integrin‐mediated destabilization of actin cytoskeleton , 2006, FEBS letters.

[44]  M. Horne,et al.  The effect of red blood cells on thrombin generation , 2006, British journal of haematology.

[45]  C. Prowse,et al.  The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components , 2006, Transfusion.

[46]  U. Martinowitz,et al.  Prerequisites for recombinant factor VIIa‐induced thrombin generation in plasmas deficient in factors VIII, IX or XI , 2006, Journal of thrombosis and haemostasis : JTH.

[47]  M. Gelderman,et al.  Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. , 2006, Transfusion medicine reviews.

[48]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[49]  R. Nieuwland,et al.  Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.

[50]  J. Duguid,et al.  Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant , 2004, British journal of haematology.

[51]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[52]  J. Strain,et al.  Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. , 1999, Methods in enzymology.

[53]  L. Sarda,et al.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.

[54]  C. Knupp,et al.  Effect of cold storage on platelet glycoprotein Ib and vesiculation , 1994, Transfusion.

[55]  A. Marcus,et al.  Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. , 1991, The Journal of clinical investigation.

[56]  C. Esmon,et al.  Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. , 1989, The Journal of biological chemistry.

[57]  R. Heinz,et al.  Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates , 1988, Transfusion.

[58]  D. Fugman,et al.  Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. , 1987, The Journal of laboratory and clinical medicine.

[59]  J. George,et al.  Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. , 1986, Blood.

[60]  J. Correia,et al.  Mechanisms of assembly and disassembly of microtubules. , 1983, Annual review of biophysics and bioengineering.